top of page
What We Do
We investigate how antibody signaling regulates innate and adaptive immunity. Our research combines antibody and immune cell engineering, identification of signaling mechanisms that drive different disease outcomes, and exploration of how glycosylation of antibodies and their receptors influences immune function. By defining these pathways, we aim to enhance vaccine efficacy and develop targeted, innovative therapies.
bottom of page